









Congenital heart disease (CHD) is one of the most common birth defects in humans. In addition, CHD is the leading cause of infant death (Heron et al, 2009). Ethylnitrosourea (ENU) is used to induce random single nucleotide polymorphisms in mice. Once the mice are have a mutation they are sent to the University of Pittsburgh for analysis to determine if the SNP is associated with cardiovascular defects. Each mutated mouse is used to breed its own mouse line. The ENU screen uses echocardiography, EFIC imaging, necropsy and exome sequencing to determine the phenotypes and genotypes of the mouse lines. The screen has identified novel genes in mice that may be potential causes of CHD in infants.   The Bench to Bassinet program is a nationwide program that translates basic science to clinical trials. As part of this program, data gathered by the ENU screen in mice is organized and available to the public through Jackson Labs Mouse Genome Informatics Database.  As of March 2013, 123 mouse lines covering many different types of cardiovascular and craniofacial defects have been made available to the public.  Public health significance:  Approximately 40,000 infants die from CHD each year (Hoffman & Kaplan, 2002; Reller et al, 2008).  This research and this database enables collaboration among many researchers to identify the causal genes of CHD in infants, and hopefully an eventual means of prophylaxis.
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Birth Defects and Congenital Heart Defects






Table 1: Birth Defects in the US from 2004-2006 (Heron et al, 2009)

Birth Defects	Cases per Births	Estimated Annual Number of Cases
Adjusted for maternal race/ethnicity		
     Central Nervous System Defects		
Anencephaly	1 in 4,859	859
Spina bifida without anencephaly	1 in 2,858	1,460
Encephalocele	1 in 12,235	341
     Eye Defects		
Anophthalmia/microphthalmia*	1 in 5,349	780
    Cardiovascular Defects		
Common truncus	1 in 13,876	301
Transposition of the great arteries*	1 in 3,333	1,252
Tetralogy of Fallot*	1 in 2,518	1,657
Atrioventricular septal defect*	1 in 2,122	1,966
Hypoplastic left heart syndrome*	1 in 4,344	960
     Orofacial Defects		
Cleft palate without cleft lip*	1 in 1,574	2,651
Cleft lip with and without cleft palate*	1 in 940	4,437
     Gastrointestinal Defects		
Esophageal atresia/tracheoesophageal fistula	1 in 4,608	905
Rectal and large intestinal atresia/stenosis	1 in 2,138	1,952
     Musculoskeletal Defects		
Reduction deformity, upper limbs	1 in 2,869	1,454
Reduction deformity, lower limbs	1 in 5,949	701
Gastroschisis	1 in 2,229	1,871
Omphalocele	1 in 5,386	775
Diaphragmatic hernia*	1 in 3,836	1,088
*Denotes defects that have been observed in the ENU Screen at Pitt






Genetics of CHD 

There is not much known about the genetics of CHD, especially in humans. Animal models, specifically mice, are the best way to study CHD because they have similar heart structure to humans. Mice have been used to study heart disease problems such as atherosclerosis, multiple MIs, and severe cardiac dysfunction, which are common heart problems in humans (Braun, 2002). 

It is estimated that approximately 15% of congenital heart defects are associated with a known genetic condition (Oyen et al, 2009; Hartman et al, 2011). Family history is currently being used to help screen at risk children for CHD. In addition to family history, bedside pulse oximetry is done on infants to check their blood oxygen level and pulse. If the infant has a low blood oxygen level further screening, echocardiogram, will be done to screen for possible heart defects. Identification of infants at risk for CHD also would be enhanced if infants (or their parents) could be screened for the presence of specific genetic variants that contribute to CHD risk .The bench to bassinet program was initiated to identify potential causal genes of CHD because if children or even parents can be screened for genes of interest then treatment can be started early. 

ENU Screen and Mice

ENU is used to induce random single nucleotide polymorphisms (SNP) in the mouse genome. This is the best way to look for potential causal genes of CHD. When there are no target genes ENU allows researchers to breed and look for cardiovascular phenotypes. Once a phenotype of interest is identified the mouse is then sent for exome sequencing to identify the SNPs in the coding region of the mutant mouse

The ethylnitrosourea (ENU) mutagenesis screen used at the University of Pittsburgh was done in mice. Inbred mouse strains were used because their genome is well understood and easily manipulated. In addition mice, like humans, have four chamber hearts with separate systemic vs. pulmonary circulation, which makes it a good animal model to study heart disease. Eight of the 21 defects in table 1 have been observed in the ENU mutagenesis screen at the University of Pittsburgh. The ENU screen uses echocardiograph, EFIC imaging, necropsy and exome sequencing to determine the phenotype and genotype of the mouse lines. The screen has identified novel genes for the potential causes of CHD (Lo, 2012). The genes were identified using exome sequencing to identify the SNPs in the genome. Once the SNPs are identified they are labeled heterozygous and homozygous. Our screen is interested in homozygous SNPs because they are more likely to be causal SNPs, since all animals carry many non-harmful SNPs. The homozygous SNPs are validated in other mutant mice until the causal SNP is found and the associated gene identified. After the SNP is identified the parents are then genotyped to determine their carrier status. For example, the screen identified the gene Foxj1. Previously, Foxj1 was known to be a transcription factor that regulated genes for the production of motile cilia and left-right asymmetry. In the screen at Pitt, Foxj1 was associated with situs inversus totalis (left-right defect) and biventricular hypertrophy (Lo, 2012).

Bench to Bassinet Program

The Bench to Bassinet (B2B) program was started by the National Heart, Lung and Blood Institute (NHLBI) as a way to better translate basic research findings to clinical studies and trials. The B2B program includes two research consortia: Pediatric Cardiac Genomics Consortium (PCGC) and the Cardiovascular Development Consortium (CvDC) and a coordinating center at New England Research Institute (NERI). There are five centers in the PCGC consortia and fours CvDC centers; the University of Pittsburgh is part of the CvDC. Figure 1 shows the flow of data through the different parts of the program and the different centers involved. There are many other collaborating hospitals and universities throughout the country that also play a role in the B2B program. The primary purpose of the PCGC is to identify genes in human CHD patients and to track patient clinical outcomes. The purpose of the CvDC consortia is study CHD at a molecular level in model organisms. The main objective of the pediatric heart network (PHN) is to improve outcomes and quality of life for children who are affected by CHD. Once data is acquired by each of the consortia, they are to share and disseminate comprehensive data so that others may continue the work. Figure 2 shows a map of where the centers are located across the country.


Figure 1: Bench to Bassinet Centers (Lauer & Skarlatos, 2010)






University of Pittsburgh ENU Screen

Mutant mouse lines are identified using many diagnostic methods to determine the phenotype of the mutant mice. First an echocardiogram is done on the pregnant mother to determine if the embryos she is carrying are mutants or if something is out of the ordinary. Echocardiograms are good at identifying blood flow patterns Second, if a mouse is thought to have defects based on the echocardiogram, a CT or MRI is done to get a closer look. After the CT or MRI is done if a defect is still suspected the mouse is necropsied. Necropsy is a useful tool to look at situs, left-right patterning, phenotypes. If the necropsy does not detect the cardiovascular defect or if a structural defect is suspected, the chest cavity of the mouse is then sent for episcopic fluorescence image capturing (EFIC) imaging. EFIC imaging produces an image stack that allows researchers to look at slices of the heart from different angles. Most of the time all or a combination of these techniques are used to determine the phenotype of a mutant mouse. 

After the diagnostic tests have been completed, the images and image stacks are uploaded to a database along with defect codes and captions. When a line has two or more mutants, laterality lines need only one mutant, it is eligible to be curated. When a mouse has an ENU induced mutation it is then breed to females and the resulting line is considered one mouse line. A laterality line a line that has heterotaxy, situs inversus totalis, or interrupted or duplicated inferior vena cava. The curation process is what a line goes through to get the data that is collected at Pitt to a central database that is publically available at the Jackson Laboratories (JAX). For a line to be eligible for JAX it must have conclusive diagnostic necropsy and EFIC data and any other supporting diagnostic tests necessary to show the phenotype.

Jackson Labs/ Bench to Bassinet Program

The main database at the University of Pittsburgh is called Lab ENU. This database contains all of the phenotype and genotype information for each mouse and each mutant line. When a mutant line is ready for curation all of the necessary images, summary sheets and image stacks get put on the mutant line page with captions. It is important to put images that are clean and clearly show the phenotype of interest because the data will be made publically available.  Figures 3 shows an example of the Lab ENU database for line 1727.






The table at the top is a list of the Fyler codes used for 1727. Below the codes is the summative diagnosis for the line followed by the human disease model, if any, and any other notes needed for the line.

The photo above shows all of the images and captions in the database that were used to show the phenotype of 1727. The photos with the pink background were taken during necropsy, the yellow background is EFIC imaging and the purple are cilia and echocardiograph data. Pictures and captions can be seen in Appendix A.

Figure 3: Lab ENU view for mouse line 1727

On the Lab ENU database there is a list of defect codes, summative diagnosis, Fyler codes, and a gene of interest (if applicable). Fyler codes (developed by The Boston Children's Heart Foundation in Boston Children's Hospital) provide a hierarchical clinical diagnosis of congenital cardiovascular defects and other disorders. These codes are used to delineate pathology in the mutant mouse models that parallel human disease and can be cross-referenced to the International Pediatric and Congenital Cardiac Code (IPCCC). The codes are a useful resource for international collaborators.

After this information is organized in the Lab ENU database at Pitt, it is made available to JAX for their database. After the information is posted on the JAX website, it can be accesed by searching for B2B lines, by a specific type of CHD, gene name or by the Fyler codes. In addition, after data about the lines are posted on the JAX website, other researchers can order frozen sperm to generate a mutant mouse line of their own. 

Bench to Bassinet Website

The data on the mutant mouse lines is also accessible from the B2B website. It is easy to search from the B2B site. If a researcher is looking for a gene identified through this program and the progress of other centers they can find that information on the B2B site. From the B2B website a researcher could search for a specific gene or phenotype identified through the program (see figure 10 in Appendix A). The information in the B2B search is obtained from JAX.
Data overview
Table 2 shows an overview of the important information from mutant line 1727. This is an example of the type of information that is necessary for a line to have before it can be made publically available. A nickname is useful because if a gene is not identified, then that is it is referred to by its nickname and not b2b1727clo.

Table 2: Information Transferred from Lab ENU to JAX
Data Name	Data from 1727
Nickname	Mickey
Defect Codes	Laterality DefectsImmotile, hyperkinetic and dyskinetic cilia
Genes	Dnahc11
Fyler Codes	DORV, Heterotaxy, {S,D,D}, etc.
Summative Diagnosis	Cardiac defects: Complex congenital heart disease associated with heterotaxy such as double outlet right ventricle (DORV) with subaortic ventricular septal defect, atrioventricular septal defect (AVSD), hypoplastic/abnormal spleenNoncardiac defects: Immotile/hyperkinetic/dyskinetic respiratory airway cilia and hydronephrosis
Human Disease Model	Primary ciliary dyskinesia, Heterotaxy, Kartagener's syndrome




This research is of public health significance because it is studying a CHD, which affects nearly 1% of babies born annually, approximately 40,000 infants, and is the leading cause of infant death (Heron et al, 200). Many infants born with CHD need increased medical care, which leads to increased healthcare costs, some infants require surgery. In most instances CHD cannot be cured because there is no cure these people require life-long care for CHD. In addition, CHD can have more effects the longer the person lives, which means they will become more expensive to the healthcare system as they age. If CHD could be detected earlier to even prevent that would lesson the need for long-term care for people living with CHD. The ability to use genetics to diagnose CHD could allow for personalized treatment plans and more individualized care.






While this study promotes collaboration and data sharing there are still some limitations. Research centers share their data but sharing within and between websites and databases can be problematic. There have been instances when data does not get released on time due to technology problems. For example, Pitt switched database programmers and JAX underwent server maintenance both of which delayed data upload. Whenever there are a lot of people involved in a project there are more ways for problems to occur. When computer systems are down at any part in the process, Pitt, JAX or NERI, it makes communication that much more important. It is important in public health to be able to maintain open communication between all collaborators to be able to help the most people. 

Future of the B2B program































Figure 7: Necropsy Image - Mutant 1727-002-LA displays bilateral duplex kidneys and severe hydroureter and hydronephrosis of the left kidney.


Figure 8: EFIC Summary Sheet – 1727-002-LA
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Preparing and Organizing Results from an ENU Mutagenesis
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